Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
5,558 people get AMGN articles and Market Currents by email alert.
Get email alerts on AMGN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (Thu, 4:18PM)
-
-
PR Newswire (Wed, 6:00PM)
-
-
-
-
-
-
-
PR Newswire (May 9, 2013)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Why Amgen Still Has Valuation Upside RemainingValuentum • Fri, Feb 15 -
-
Is Amgen Running Out Of Steam In 2013?StockRiters • Tue, Jan 22 -
-
-
-
-
-
-
Amgen Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 23, 2012
-
Amgen Management Discusses Q2 2012 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
Amgen's CEO Discusses Q1 2012 Results - Earnings Call TranscriptTue, Apr 24, 2012
-
Amgen's CEO Discusses Q4 2011 Results - Earnings Call TranscriptThu, Jan 26, 2012
-
Amgen's CEO Discusses Q3 2011 Results - Earnings Call TranscriptMon, Oct 24, 2011
-
Amgen's CEO Discusses Q2 2011 Results - Earnings Call TranscriptFri, Jul 29, 2011
-
Amgen's CEO Discusses Q1 2011 Results - Earnings Call TranscriptWed, Apr 20, 2011
-
Amgen's CEO Discusses Q4 2010 Results - Earnings Call TranscriptTue, Jan 25, 2011
-
Amgen Management Discusses Q3 2010 Results - Earnings Call TranscriptTue, Oct 26, 2010
-
Amgen Q2 2010 Earnings Call TranscriptFri, Jul 30, 2010
-
Amgen Inc. Q1 2010 Earnings Call TranscriptThu, Apr 22, 2010
-
Amgen, Inc. Q4 2009 Earnings Call TranscriptMon, Jan 25, 2010
-
Amgen, Inc. Q3 2009 Earnings Call TranscriptWed, Oct 21, 2009
-
Amgen, Inc. Q2 2009 Earnings Call TranscriptTue, Jul 28, 2009
-
Amgen Inc., F1Q09Earnings Call TranscriptThu, Apr 23, 2009
-
at CNBC.com (Mon, 6:43PM)
-
PR Newswire (Thu, 4:18PM)
-
PR Newswire (Wed, 6:00PM)
-
PR Newswire (May 9, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at MarketWatch.com (Apr 26, 2013)
-
at CNBC.com (Apr 24, 2013)
-
at CNBC.com (Apr 24, 2013)
-
at MarketWatch.com (Apr 24, 2013)
-
at CNBC.com (Apr 24, 2013)
-
at CNBC.com (Apr 24, 2013)
-
at CNBC.com (Apr 23, 2013)
-
at CNBC.com (Apr 23, 2013)
-
at CNBC.com (Apr 23, 2013)
-
at MarketWatch.com (Apr 23, 2013)
AMGN vs. ETF Alternatives
Company Description
Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” and “us”) is the world’s largest independent biotechnology medicines company. We discover, develop, manufacture and market medicines for grievous illnesses. We focus solely on human therapeutics and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, June 2, 2010, 3:57 PM Amgen (AMGN +10.8%) shares soar today after the FDA clears marketing of its Prolia drug as a treatment for postmenopausal osteoporosis. Comment!
-
Wednesday, June 2, 2010, 9:00 AM
Premarket gainers: GNA +59%. DIVX +30%. AVII +9%. ABK +7%. HERO +7%. ARNA +6%. CTIC +5%. AMGN +5%. TSEM +5%. IRE +4%.
Losers: CSIQ -19%. PVG -7%. AIB -5%. Comment! - Wednesday, June 2, 2010, 7:28 AM Amgen (AMGN +4.4%) gets key FDA clearance for Prolia, its injectable bone strengthening drug. It's a potential blockbuster market, and analysts believe Amgen could make billions of dollars in revenue from Prolia's launch. 1 Comment
- Friday, May 28, 2010, 9:23 AM Amgen's (AMGN) new drug Prolia for treatment of osteoporosis wins approval for sale in Europe. GlaxoSmithKline (GSK) will market the drug, throwing its weight behind a product that industry analysts expect to make billions of dollars in annual sales. AMGN +1%, GSK +1.7% premarket. (PR) Comment!
- Wednesday, April 21, 2010, 4:19 PM Amgen (AMGN): Q1 EPS of $1.30 beats by $0.06. Revenue of $3.59B (+8.6%) vs. $3.65B. Shares -1.9% AH. (PR) Comment!
- Wednesday, April 21, 2010, 12:10 AM Notable earnings after Wednesday's close: ACF, ADS, AFFX, AMGN, CPX, CTXS, CVA, CYH, EBAY, ETFC, FFIV, FNF, HCBK, ISIL, LEG, LRCX, MEE, NE, NFLX, NVLS, PLCM, PTV, QCOM, SBUX, SLM, SNDK, TER, TEX, URI, VRTX Comment!
- Tuesday, February 16, 2010, 9:55 AM New Medicare rules may help little-known Affymax (AFFY +0.2%) grab market share from Amgen's (AMGN -0.2%) $2.6B anemia drug Epogen with a treatment set to be approved next year. Comment!
- Monday, January 25, 2010, 4:10 PM Amgen (AMGN): Q4 EPS of $1.05 misses by $0.08. Revenue of $3.8B (+2%) vs. $3.85B. Expects fiscal 2010 capex of about $600M. Shares -0.4% AH. (PR) Comment!
- Monday, January 25, 2010, 12:10 AM Notable earnings after Monday's close: AAPL, AMGN, ATHR, JEC, OLN, PKG, SLG, TXN, VMW, ZION Comment!
- Thursday, January 7, 2010, 10:18 AM Amgen (AMGN) -2.4% on news the FDA plans to discuss the safety of two of its top-selling drugs. Comment!
- Tuesday, December 29, 2009, 5:20 PM The quants at Credit Suisse identify 24 Buffett-esque stocks: AFAM, AMGN, APEI, ATRI, AZZ, BKE, BUCY, BYI, CHD, EME, ENSG, JNJ, JOSB, KNSY, LINC, NPK, PETS, POWL, ROST, SCL, TJX, TNDM, VAR, WMS. 2 Comments
-
Tuesday, December 22, 2009, 10:23 AM
Winners in the Senate healthcare reform:
- Drug and device makers (PFE, MRK, BSX, MDT)
- Hospitals (UHS, THC)
- Biologics (AMGN)
- Cosmetics (JNJ, AGN)
- Home healthcare providers (AMED, ADUS, GTIV)
Losers:
- Health insurers (WLP, UNH, AET)
- Generic drugmakers
- Pharmacy benefit managers (MHS, CVS, ESRX)
- Nursing homes (SKH, KND) 13 Comments - Monday, December 7, 2009, 9:08 AM Amgen (AMGN) approves another $5B in share buybacks, additive to its current $1.2B. "This new authorization reflects Amgen's confidence in its long-term prospects." Shares +0.5% premarket. (PR) Comment!
- Friday, October 30, 2009, 2:06 PM Fourteen states and the District of Columbia sue Amgen (AMGN -1.2%), charging the company with offering kickbacks to push sales of anemia drug Aranesp. 1 Comment
- Wednesday, October 21, 2009, 4:14 PM Amgen (AMGN): Q3 EPS of $1.49 beats by $0.22. Revenue of $3.8B (-2%) in-line. Raises full-year EPS guidance to $4.90-5.05 from $4.80-4.95, vs. $4.88. Shares +0.7% AH. (PR) Comment!
- Wednesday, October 21, 2009, 12:10 AM Notable post-market earnings: ADS, AMGN, AMP, CTXS, CVA, EBAY, EFX, FFIV, FIS, FNF, ISIL, KNX, LOGI, LRCX, NE, NFX, NVLS, OSIP, PTV, QLGC, RRC, SKX, TEX, TQNT, VMW Comment!
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
O. Young Kwon
Amgen (AMGN), Cimex (CX), Accenture (ACN), and Baidu (BIDU) have their TANER momentum. See " Income Portfolio Adjustments by the TMT..."yk - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES